XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning Balance at Dec. 31, 2020 $ 342,367 $ 5 $ 421,572 $ (27) $ (79,183)
Beginning Balance, Shares at Dec. 31, 2020   45,076,574      
Issuance of stock, net of issuance costs 157,237 $ 1 157,236    
Issuance of stock, net of issuance costs, Shares   6,000,000      
Exercise of stock options 13   13    
Exercise of stock options, Shares   11,163      
Stock-based compensation 3,652   3,652    
Vesting of restricted shares   70,539      
Unrealized losses (gain) on marketable securities (41)     (41)  
Net loss (24,968)       (24,968)
Ending Balance at Mar. 31, 2021 478,260 $ 6 582,473 (68) (104,151)
Ending Balance, Shares at Mar. 31, 2021   51,158,276      
Beginning Balance at Dec. 31, 2020 342,367 $ 5 421,572 (27) (79,183)
Beginning Balance, Shares at Dec. 31, 2020   45,076,574      
Unrealized losses (gain) on marketable securities (14)        
Net loss (54,923)        
Ending Balance at Jun. 30, 2021 452,596 $ 6 586,737 (41) (134,106)
Ending Balance, Shares at Jun. 30, 2021   51,232,341      
Beginning Balance at Mar. 31, 2021 478,260 $ 6 582,473 (68) (104,151)
Beginning Balance, Shares at Mar. 31, 2021   51,158,276      
Exercise of stock options 25   25    
Exercise of stock options, Shares   10,088      
Stock-based compensation 4,239   4,239    
Vesting of restricted shares   63,977      
Unrealized losses (gain) on marketable securities 27     27  
Net loss (29,955)       (29,955)
Ending Balance at Jun. 30, 2021 452,596 $ 6 586,737 (41) (134,106)
Ending Balance, Shares at Jun. 30, 2021   51,232,341      
Beginning Balance at Dec. 31, 2021 368,197 $ 6 596,934 (269) (228,474)
Beginning Balance, Shares at Dec. 31, 2021   51,569,381      
Exercise of stock options 18   18    
Exercise of stock options, Shares   9,583      
Stock-based compensation 4,488   4,488    
Vesting of restricted shares   20,504      
Vesting of restricted stock units   49,955      
Unrealized losses (gain) on marketable securities (661)     (661)  
Net loss (35,583)       (35,583)
Ending Balance at Mar. 31, 2022 336,459 $ 6 601,440 (930) (264,057)
Ending Balance, Shares at Mar. 31, 2022   51,649,423      
Beginning Balance at Dec. 31, 2021 $ 368,197 $ 6 596,934 (269) (228,474)
Beginning Balance, Shares at Dec. 31, 2021   51,569,381      
Exercise of stock options, Shares 41,950        
Unrealized losses (gain) on marketable securities $ (887)        
Net loss (87,887)        
Ending Balance at Jun. 30, 2022 287,059 $ 6 604,570 (1,156) (316,361)
Ending Balance, Shares at Jun. 30, 2022   51,734,361      
Beginning Balance at Mar. 31, 2022 336,459 $ 6 601,440 (930) (264,057)
Beginning Balance, Shares at Mar. 31, 2022   51,649,423      
Exercise of stock options 99   99    
Exercise of stock options, Shares   32,367      
Stock-based compensation 3,031   3,031    
Vesting of restricted shares   10,664      
Vesting of restricted stock units   41,907      
Unrealized losses (gain) on marketable securities (226)     (226)  
Net loss (52,304)       (52,304)
Ending Balance at Jun. 30, 2022 $ 287,059 $ 6 $ 604,570 $ (1,156) $ (316,361)
Ending Balance, Shares at Jun. 30, 2022   51,734,361